MONECO Advisors LLC Takes Position in DocuSign, Inc. (NASDAQ:DOCU)

MONECO Advisors LLC acquired a new position in DocuSign, Inc. (NASDAQ:DOCU) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 17,030 shares of the company’s stock, valued at approximately $1,532,000.

A number of other large investors have also modified their holdings of DOCU. Toronto Dominion Bank increased its stake in shares of DocuSign by 30.3% in the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock valued at $1,624,000 after purchasing an additional 6,081 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in DocuSign by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock worth $82,478,000 after buying an additional 16,014 shares in the last quarter. International Assets Investment Management LLC grew its holdings in DocuSign by 5,660.8% in the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock worth $27,252,000 after buying an additional 431,295 shares in the last quarter. Quantinno Capital Management LP increased its position in DocuSign by 39.5% in the 3rd quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock valued at $12,514,000 after acquiring an additional 57,104 shares during the period. Finally, Robeco Institutional Asset Management B.V. raised its stake in DocuSign by 7.1% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock valued at $80,501,000 after acquiring an additional 85,987 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insider Transactions at DocuSign

In related news, CEO Allan C. Thygesen sold 7,763 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total value of $625,232.02. Following the completion of the transaction, the chief executive officer now owns 100,062 shares in the company, valued at $8,058,993.48. This trade represents a 7.20 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Teresa Briggs sold 534 shares of the business’s stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $94.60, for a total value of $50,516.40. Following the sale, the director now owns 7,736 shares in the company, valued at approximately $731,825.60. The trade was a 6.46 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 693,773 shares of company stock valued at $66,727,926 over the last three months. Company insiders own 1.66% of the company’s stock.

DocuSign Stock Performance

NASDAQ DOCU opened at $83.96 on Monday. The stock has a market capitalization of $16.96 billion, a P/E ratio of 17.31, a P/E/G ratio of 6.94 and a beta of 0.89. The business’s fifty day moving average is $91.73 and its two-hundred day moving average is $76.87. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on DOCU shares. Jefferies Financial Group raised their price target on DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. JPMorgan Chase & Co. raised their target price on shares of DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Tuesday, December 3rd. Robert W. Baird raised their target price on shares of DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. UBS Group upped their price target on shares of DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Finally, Wells Fargo & Company raised their price objective on shares of DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $92.45.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.